Director Frank Morich Acquires 15,000 Shares of Perspective Therapeutics at $0.9971 Each
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Director Frank Morich has purchased 15,000 shares of Perspective Therapeutics, Inc. common stock at $0.9971 per share. This transaction, disclosed in a Form 4 filing with the SEC on November 16, 2026, marks his initial direct beneficial ownership of the company's shares. The acquisition took place on November 12, 2026, and was not executed under a Rule 10b5-1(c) trading plan.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.